Loading clinical trials...

Your health journey, clearly organized.

Legal

Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT07255443

Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital

significant benefits by providing data to improve infection control, guide early detection, and reduce CRE transmission in ICUs.

Lead sponsor: Israa Ahmed abdelhalim•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment120

Start dateFeb 2026

Last updatedDec 1, 2025

Condition

Rate of Carbapenemase Intestinal Carrier Inside ICU

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 1, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions